proline and glucagon-like peptide 1

proline has been researched along with glucagon-like peptide 1 in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Bailey, CJ; Flatt, PR; Gault, VA; Green, BD; Greer, B; Harriott, P; Irwin, N; Mooney, MH; O'Harte, FP	1
Gillespie, DG; Jackson, EK; Kochanek, SJ	1
Ardévol, A; Blay, M; González-Abuín, N; Green, BD; Martínez-Micaelo, N; Pinent, M	1
Baek, S; Choi, J; Frias, JP; Muehlen-Bartmer, I; Niemoeller, E; Popescu, L; Rosenstock, J	1
Batra, Y; Jaglan, S; Kaur, B; Rani, S; Singh, P	1

Trials

1 trial(s) available for proline and glucagon-like peptide 1

Article	Year
Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial. Diabetes care, 2022, 07-07, Volume: 45, Issue:7 Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Proline; Treatment Outcome	2022

Article

Year

Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial.

Diabetes care, 2022, 07-07, Volume: 45, Issue:7

Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Proline; Treatment Outcome

2022

Other Studies

4 other study(ies) available for proline and glucagon-like peptide 1

Article	Year
Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1. Biological chemistry, 2003, Volume: 384, Issue:12 Topics: Adenosine Deaminase; Amino Acid Substitution; Animals; Binding, Competitive; Blood Glucose; Cell Line, Tumor; Cricetinae; Cyclic AMP; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fibroblasts; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glutamine; Glycoproteins; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Obese; Peptide Fragments; Phenylalanine; Proline; Protein Precursors; Rats; Receptors, Glucagon; Spectrometry, Mass, Electrospray Ionization; Transformation, Genetic; Tyrosine	2003
Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:3 Topics: Animals; Arginine; Cell Proliferation; Cells, Cultured; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Glomerular Mesangium; Glucagon-Like Peptide 1; Male; Models, Animal; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptide YY; Proline; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sitagliptin Phosphate; Thymidine; Triazoles	2012
Grape-seed procyanidins modulate cellular membrane potential and nutrient-induced GLP-1 secretion in STC-1 cells. American journal of physiology. Cell physiology, 2014, Mar-01, Volume: 306, Issue:5 Topics: Animals; Cell Line; Cell Line, Tumor; Cell Membrane; Dose-Response Relationship, Drug; Enteroendocrine Cells; Food-Drug Interactions; Glucagon-Like Peptide 1; Glucose; Grape Seed Extract; Linoleic Acid; Membrane Potential, Mitochondrial; Membrane Potentials; Mice; Proanthocyanidins; Proline; Time Factors	2014
Proline based rationally designed peptide esters against dipeptidyl peptidase-4: Highly potent anti-diabetic agents. Bioorganic & medicinal chemistry letters, 2022, 11-15, Volume: 76 Topics: Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Drug Design; Esters; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Hypoglycemic Agents; Oligopeptides; Proline; Sitagliptin Phosphate	2022